Literature DB >> 9802906

Morphogenetic effects of neuregulin (neu differentiation factor) in cultured epithelial cells.

A Chausovsky1, I Tsarfaty, Z Kam, Y Yarden, B Geiger, A D Bershadsky.   

Abstract

Neuregulin, or neu differentiation factor, induces cell proliferation or differentiation through interaction with members of the ErbB family of receptor tyrosine kinases. We report that neuregulin can also induce profound morphogenic responses in cultured epithelial cells of different origins. These effects include scattering of small epithelial islands and rearrangement of larger cell islands into ordered ring-shaped arrays with internal lumens. The ring-forming cells are interconnected by cadherin- and beta-catenin-containing adherens junctions. In confluent cultures, neuregulin treatment induces formation of circular lumenlike gaps in the monolayer. Both cell scattering and ring formation are accompanied by a marked increase in cell motility that is independent of hepatocyte growth factor/scatter factor and its receptor (c-Met). Affinity-labeling experiments implied that a combination of ErbB-2 with ErbB-3 mediates the morphogenic signal of neuregulin in gastric cells. Indeed, a similar morphogenic effect could be reconstituted in nonresponsive cells by coexpression of ErbB-2 and -3. We conclude that a heterodimer between the kinase-defective neuregulin receptor, ErbB-3, and the coreceptor, ErbB-2, mediates the morphogenetic action of neuregulin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9802906      PMCID: PMC25609          DOI: 10.1091/mbc.9.11.3195

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  51 in total

1.  Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis.

Authors:  K M Weidner; S Di Cesare; M Sachs; V Brinkmann; J Behrens; W Birchmeier
Journal:  Nature       Date:  1996-11-14       Impact factor: 49.962

Review 2.  Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis.

Authors:  S Burden; Y Yarden
Journal:  Neuron       Date:  1997-06       Impact factor: 17.173

3.  Phosphatidylinositol 3-kinase signals activate a selective subset of Rac/Rho-dependent effector pathways.

Authors:  K Reif; C D Nobes; G Thomas; A Hall; D A Cantrell
Journal:  Curr Biol       Date:  1996-11-01       Impact factor: 10.834

Review 4.  Control of invasive growth by hepatocyte growth factor (HGF) and related scatter factors.

Authors:  L Tamagnone; P M Comoglio
Journal:  Cytokine Growth Factor Rev       Date:  1997-06       Impact factor: 7.638

5.  Met -/- kidneys express epithelial cells that chemotax and form tubules in response to EGF receptor ligands.

Authors:  C Kjelsberg; H Sakurai; K Spokes; C Birchmeier; I Drummond; S Nigam; L G Cantley
Journal:  Am J Physiol       Date:  1997-02

6.  Severe neuropathies in mice with targeted mutations in the ErbB3 receptor.

Authors:  D Riethmacher; E Sonnenberg-Riethmacher; V Brinkmann; T Yamaai; G R Lewin; C Birchmeier
Journal:  Nature       Date:  1997-10-16       Impact factor: 49.962

7.  A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor.

Authors:  E Tzahar; H Waterman; X Chen; G Levkowitz; D Karunagaran; S Lavi; B J Ratzkin; Y Yarden
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

8.  HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor.

Authors:  J Lee; T J Dull; I Lax; J Schlessinger; A Ullrich
Journal:  EMBO J       Date:  1989-01       Impact factor: 11.598

9.  Regulation of cell motility by mitogen-activated protein kinase.

Authors:  R L Klemke; S Cai; A L Giannini; P J Gallagher; P de Lanerolle; D A Cheresh
Journal:  J Cell Biol       Date:  1997-04-21       Impact factor: 10.539

10.  The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition.

Authors:  P Savagner; K M Yamada; J P Thiery
Journal:  J Cell Biol       Date:  1997-06-16       Impact factor: 10.539

View more
  9 in total

1.  Dynamics of adherence junctions during early stages of epithelial-mesenchymal transition: possible mechanisms of tube and alveolus formation in ontogeny.

Authors:  S N Rubtsova; Yu M Vasiliev
Journal:  Dokl Biol Sci       Date:  2010 Jan-Feb

2.  GGF2 is neuroprotective in a rat model of cavernous nerve injury-induced erectile dysfunction.

Authors:  Arthur L Burnett; Sena F Sezen; Ahmet Hoke; Anthony O Caggiano; Jennifer Iaci; Gwen Lagoda; Biljana Musicki; Anthony J Bella
Journal:  J Sex Med       Date:  2015-01-30       Impact factor: 3.802

3.  Overexpression of NRG1 promotes progression of gastric cancer by regulating the self-renewal of cancer stem cells.

Authors:  Myoung-Eun Han; Hyun-Jung Kim; Dong Hoon Shin; Sun-Hwi Hwang; Chi-Dug Kang; Sae-Ock Oh
Journal:  J Gastroenterol       Date:  2014-11-08       Impact factor: 7.527

Review 4.  Roles for neuregulins in human cancer.

Authors:  Christophe Stove; Marc Bracke
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

Review 5.  The ERBB3 receptor in cancer and cancer gene therapy.

Authors:  G Sithanandam; L M Anderson
Journal:  Cancer Gene Ther       Date:  2008-04-11       Impact factor: 5.987

6.  HGF converts ErbB2/Neu epithelial morphogenesis to cell invasion.

Authors:  Hanane Khoury; Monica A Naujokas; Dongmei Zuo; Veena Sangwan; Melanie M Frigault; Stephanie Petkiewicz; David L Dankort; William J Muller; Morag Park
Journal:  Mol Biol Cell       Date:  2004-11-17       Impact factor: 4.138

7.  ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases.

Authors:  K S Spencer; D Graus-Porta; J Leng; N E Hynes; R L Klemke
Journal:  J Cell Biol       Date:  2000-01-24       Impact factor: 10.539

Review 8.  Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models.

Authors:  D Rice; S Barone
Journal:  Environ Health Perspect       Date:  2000-06       Impact factor: 9.031

9.  Gastric Cancer Harboring an ERBB3 Mutation Treated with a Pyrotinib-Irinotecan Combo: A Case Study.

Authors:  Kailin Ding; Xian Chen; Yong Li; Wenzhu Li; Yongsong Ye; Tingting He; Wenjing Wang; Haibo Zhang
Journal:  Onco Targets Ther       Date:  2021-01-18       Impact factor: 4.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.